RE:RE:RE:Is the earn out not a good thing?Jacking up prices of old drugs is no longer part of Concordia business plan. Market growth and share penetration and new drugs will be. Nobody looks back anymore, just shorty trying to scare longs into selling. Nobody listens to shorts anymore either,except maybe newbie novice investors deciding an entry point. Do your DD.